Top

Published in:

01-01-2014 | Letter to Editor

Avoidance behavior towards physical activity in chronic fatigue syndrome and fibromyalgia: the fear for post-exertional malaise

Authors: Jo Nijs, Mari Lundberg

Published in: Clinical Rheumatology | Issue 1/2014

Excerpt

We have read the Letter to the Editor written by Dr. Enlander [1] who commented on our review article addressing fear of movement and avoidance behavior towards physical activity in patients with chronic fatigue syndrome (CFS) and fibromyalgia (FM) [2]. We would like to thank Dr. Enlander for his interest in our review paper and for his efforts in stimulating international debate in this area. However, we feel that Dr. Enlander's letter is offline with the scope of the review article and, therefore, would like to take the opportunity to restore the focus. …

Enlander D (2013) Fear of movement and avoidance behaviour toward physical activity in chronic-fatigue syndrome and fibromyalgia: state of the art and implications for clinical practice. Clin Rheumatol 32(7):1113. doi:10.1007/s10067-013-2295-2 PubMedCrossRef

Nijs J et al (2013) Fear of movement and avoidance behaviour toward physical activity in chronic-fatigue syndrome and fibromyalgia: state of the art and implications for clinical practice. Clin Rheumatol 32(8):1121–1129PubMedCrossRef

Ohashi K, Yamamoto Y, Natelson BH (2002) Activity rhythm degrades after strenuous exercise in chronic fatigue syndrome. Physiol Behav 77(1):39–44PubMedCrossRef

Sorensen B et al (2003) Complement activation in a model of chronic fatigue syndrome. J Allergy Clin Immunol 112(2):397–403PubMedCrossRef

Nijs J et al (2010) Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta. J Intern Med 267(4):418–435PubMedCrossRef

Jammes Y et al (2005) Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med 257(3):299–310PubMedCrossRef

Nijs J et al (2005) Chronic fatigue syndrome: exercise performance related to immune dysfunction. Med Sci Sports Exerc 37(10):1647–1654PubMedCrossRef

Light AR et al (2012) Gene expression alterations at baseline and following moderate exercise in patients with chronic fatigue syndrome and fibromyalgia syndrome. J Intern Med 271(1):64–81PubMedCentralPubMedCrossRef

Light AR et al (2009) Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J Pain 10:1099–1112PubMedCentralPubMedCrossRef

10.

LaManca JJ et al (1999) Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. J Clin Immunol 19(2):135–142PubMedCrossRef

11.

Van Oosterwijck J et al (2010) Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J Intern Med 268(3):265–278PubMedCrossRef

12.

Kosek E, Ekholm J, Hansson P (1996) Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 64(3):415–423PubMedCrossRef

13.

Lannersten L, Kosek E (2010) Dysfunction of endogenous pain inhibition during exercise with painful muscles in patients with shoulder myalgia and fibromyalgia. Pain 151(1):77–86PubMedCrossRef

Title: Avoidance behavior towards physical activity in chronic fatigue syndrome and fibromyalgia: the fear for post-exertional malaise
Authors: Jo Nijs
Mari Lundberg
Publication date: 01-01-2014
Publisher: Springer London
Published in: Clinical Rheumatology / Issue 1/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-013-2421-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2014

Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years

High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register

Factors associated with methotrexate dosing and therapeutic decisions in veterans with rheumatoid arthritis

Noninvasive evaluation of cardiac autonomic modulation in children with primary Raynaud’s phenomenon: a controlled study

Clinical Rheumatology: building-up on past success

Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials